Form 8-K Summit Therapeutics Inc. For: Apr 02
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/17/2026
- Wall Street ends lower as chip weakness offsets solid earnings, economic data
- Netflix earnings forecast disappoints Wall Street, shares tumble
- Alphabet stock falls on report of Gemini AI model delays
- TSMC Q2 profit jumps 77% to record, far surpasses expectations
- Oil settles lower, but remains near one-month high on U.S.-Iran tension
- FDA approves Merck's Lipfendra as first oral PCSK9 inhibitor
- Wall Street ends lower as chip weakness offsets solid earnings, economic data
- Intuitive Surgical (ISRG) Tops Q2 EPS by 29c, Beats on Revenue
- Personalis (PSNL) explores potential sale after interest from Merck and others - source
- Boeing nears approval of 737 MAX anti-ice fix, paving way for deliveries
Summit Therapeutics (SMMT) Announces CFO Resignation
April 3, 2024 4:45 PM EDTOn April 2, 2024, Ankur Dhingra, the principal financial officer and principal accounting officer of Summit Therapeutics (NASDAQ: SMMT), resigned as Chief Financial Officer of the Company. Mr. Dhingras resignation was not due to any disagreement with the Company relating to its operations,... More
